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ABSTRACT
Background. Modern modeling techniques, including decision trees, may potentially provide accurate pre-
diction and classification of outcomes, and support the process of clinical decision making. The objective 
of our study was to evaluate the performance of triglyceride to high-density lipoprotein (TG:HDL-C) ratio 
in acute coronary syndromes (ACS) presented using a decision tree analysis. 
Methods. The initial study group consisted of 220 consecutive patients admitted to hospital within the first 
6 hours from the onset of chest pain. All these patients met clinical criteria of ACS and were compared with 
116 healthy volunteers in a case-control study. Serum was assayed on admission for cardiac troponin I, 
C-reactive protein, apolipoproteins ApoAI and ApoB, and lipid parameters. Atherogenic lipid ratios: TC:HDL:C, 
LDL-C:HDL:C and TG:HDL-C were calculated. 
Results. ACS patients showed almost twice as high median values of TG:HDL-C as controls [2.77 (1.88–4.08) 
vs. 1.47 (0.99–2.08); p < 0.0001]. The TG:HDL-C ratio was significantly related to the positive history of 
coronary artery disease, age and lipid parameters, except for LDL-C. The TG:HDL-C ratio was, after age, 
the most powerful independent predictor and classifier of the occurrence of ACS with the optimal cutoff 
being 2.28. The performance of TG:HDL-C was superior to other lipid parameters and ratios, and enabled 
identification of the additional 6 subjects with ACS.
Conclusion. The TG:HDL-C ratio is a useful risk marker of the ACS occurrence. Further prospective studies 
are needed to confirm our findings and clarify the interaction between TG and HDL-C concentrations in 
ACS patients.
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Introduction
The identification and estimation of multiple risk 
factors are recommended by the guidelines for cardio-
vascular prevention and may support clinical decision 
making. In the past few decades, the cholesterol hy-
pothesis has identified cholesterol as a major cause of 
atherosclerosis, and low-density lipoprotein cholesterol 
(LDL-C) has become the main goal for therapy. How-
ever, recently the population has become increasingly 
unhealthy, overweight or obese, with a growing number 
of adverse metabolic disorders, including insulin re-
sistance, hypertension, metabolic syndrome, diabetes 
and coronary artery disease (CAD). Most of them are 
characterized by abnormalities of lipid metabolism, 
including atherogenic dyslipidemia with a special 
emphasis on so-called triglyceride to high-density 
lipoprotein axis disorders, consisting of high concen-
trations of triglycerides (TG) and low concentrations of 
high-density lipoprotein cholesterol (HDL-C). Despite 
the unquestionable success associated with statin 
therapy, a majority of statin-treated patients continue to 
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show the evidence of dyslipidemia. Moreover, all statin 
trials showed a substantial residual risk, even among 
patients who achieved LDL-C concentration below 
70 mg/dL. Results of a meta-analysis on statin thera-
py showed that lowering LDL-C by 1 mmol/L reduces 
major coronary events by 23%, leaving an unaddressed 
cardiovascular residual risk of 77% [1, 2]. Subsequent 
studies indicated that aggressive lowering of LDL-C with 
maximal doses of statins does not eliminate cardiovas-
cular risk, which was further reduced by only 22% [2]. 
This contributed to the intensification of actions aimed to 
clarify the mechanisms that cause lipid abnormalities, as 
well as better understanding of the role of other, beyond 
LDL-C, lipid risk factors for cardiovascular risk. Until re-
cently, it was considered that elevated TG concentrations 
predict future coronary events in univariate analysis, but 
the impact was weakened after adjustment for other 
covariates which were strongly negatively correlated 
to TG, such as HDL-C [3]. This led to the reduction of 
the significance of TG role in the assessment of cardio-
vascular risk. However, over the past decade, evidence 
of the importance of TG:HDL-C abnormalities can be 
seen in several studies, which explained much of the 
pathophysiology of TG:HDL-C disorders. High TG con-
centrations can result in both low HDL-C and low LDL-C 
concentrations leading to a state in which the residual 
risk persists. A better understanding of lipoprotein-related 
residual risk with simultaneously better risk assessment 
strategy, regardless of LDL-C concentrations, should 
contribute to the improvement of patient care. 
Modern modeling techniques, including decision 
trees, may potentially provide accurate prediction and 
classification of outcomes, and support the process 
of clinical decision making. The objective of our study 
was to evaluate the performance of TG:HDL-C in acute 
coronary syndromes presented using a decision tree 
analysis. 
Material and methods
The study was designed as a case-control study. 
Consecutive patients were admitted, due to the initial 
diagnosis of acute coronary syndrome (ACS), to the 
Department of Cardiology and Internal Medicine at the 
University Hospital in Bydgoszcz within the first 6 hours 
from the onset of chest pain. The exclusion criteria were 
as follows: 1) chronic heart failure (New York Heart 
Association class II–IV); 2) acute heart failure (Killip 
class II–IV); 3) pulmonary embolism within 6 months 
preceding the enrollment; 4) creatinine concentra-
tion > 176.8 mmol/L; 5) ACS within 6 weeks preceding 
the enrollment; 6) the presence of features suggestive 
of an active inflammatory process on admission, and 
7) therapy with steroids, immunosuppressive agents, 
and nonsteroidal anti-inflammatory drugs (excluding 
low doses of aspirin). Among 267 subjects who fulfilled 
the requirements of the study according to the inclusion 
and exclusion criteria, 47 patients were diagnosed with 
unspecified chest pain or other heart diseases and 
were excluded from further analysis. Therefore, the 
final study group consisted of 220 patients (91 females 
and 129 males, aged 64 ± 12 years). All these patients 
met clinical criteria of ACS. Electrocardiographic ex-
amination was performed on admission and thereafter 
if clinically indicated. Echocardiography, stress tests, 
and cardiac catheterization were performed if needed. 
Clinically healthy volunteers (61 women and 55 men, 
aged 52 ± 9 years) with no evidence of present renal, 
metabolic or inflammatory disease, heart failure, and 
recent myocardial infarction served as controls. Base-
line characteristics of study participants are presented 
in Table 1.
The study protocol was approved by the Bioethics 
Committee of Collegium Medicum in Bydgoszcz at 
the Nicolaus Copernicus University in Torun and writ-
ten informed consent was obtained from all patients 
and controls.
Fasting venous blood samples from controls were 
collected in the morning. Venous blood samples were 
collected from patients on hospital admission within 
6 hours of chest pain onset. Serum was assayed on 
admission for cardiac troponin I (cTnI) and lipid pa-
rameters (ARCHITECT ci8200, Abbott Diagnostics). 
Any increase of cTnI above 0.032 ng/mL (the 99th 
percentile for the healthy population measured with 
a 10% coefficient of variation) was considered a pos-
itive result. High-sensitivity C-reactive protein (CRP) 
was measured using the BN II System nephelometer 
(N High-Sensitivity CRP; Siemens Healthcare Diag-
nostics, Deerfield, IL, USA). Serum apolipoprotein AI 
(ApoAI) and apolipoprotein B (ApoB) concentrations 
were measured in samples stored frozen at –80°C for 
no longer than 6 months (ARCHITECT ci8200) and the 
ratio of ApoB : ApoAI was calculated. Serum total choles-
terol (TC), TG, and HDL-C concentrations were used to 
calculate following lipid ratios: TC:HDL-C, LDL-C:HDL-C 
and TG:HDL-C. The optimal lipid cutoffs were defined 
as follows: TC < 200 mg/dL, LDL-C < 100 mg/dL, 
HDL-C > 50 mg/dL for women and > 40 mg/dL for 
men, and TG < 150 mg/dL according to the modified 
definition of the Third Report of the National Cholesterol 
Education Program [4]. TC:HDL-C < 4 and TG:HDL-C 
< 3 were regarded as optimal.
Statistical analysis
Basic statistical analysis
The patient data were expressed as mean ± stan-
dard deviation and median with 25th–75th percentiles 
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Table 1. Baseline characteristics of the study participants
Parameter
ACS patients
n = 220
Control group
n = 116 p
Age (years) 64.3 ± 12.1 52.1 ± 9.3 0.01
TC [mg/dL] 192 (159–232) 184 (165–197) 0.024
LDL-C [mg/dL] 123 (91–153) 108 (89–122) 0.002
HDL-C [mg/dL] 44.9 ± 12.1 56.1 ± 12.0 < 0.0001
non-HDL-C[mg/dL] 149 (120–180) 124 (108–137) < 0.0001
TG [mg/dL] 116 (88–168) 81.5 (63–166.5) < 0.0001
TC:HDL-C 4.43 (3.72–5.42) 3.23 (2.82–3.72) < 0.0001
TG:HDL-C 2.77 (1.88–4.08) 1.47 (0.99–2.08) < 0.0001
LDL-C:HDL-C 2.77 (2.16–3.55) 1.85 (1.56–2.27) < 0,0001
ApoAI [g/L] 1.27 ± 0.24 1.41 ± 0.31 < 0.0001
ApoB [g/L] 0.81 (0.65–1.00) 0.72 (0.61–0.86) 0.0009
ApoB:ApoAI 0.64 (0.52–0.8) 0.51 (0.45–0.62) < 0.0001
CRP [mg/L] 2.79 (1.12–6.08) 0.69 (0.36–1.35) < 0.0001
BMI [kg/m2] 26.8 (24.5–29.8) 24.4 (22.1–27.7) 0.014
Women 41% (91) 47% (55)
Men 59% (129) 53% (61)
Dyslipidemia 87% (191) 57% (66) < 0.00001
Hypertension 74% (163) 20% (23) < 0.00001
Diabetes mellitus 26% (57) 0 < 0.00001
Smoking 54% (119) 27% (31) 0.0001
Family history of premature CAD 35% (77) 26% (30) 0.29
TC — total cholesterol; LDL-C — low-density lipoprotein cholesterol; HDL-C — high-density lipoprotein cholesterol, TG — triglycerides; ApoAI  
— apolipoprotein A-I; ApoB — apolipoprotein B; BMI — body mass index; CRP — C-reactive protein; CAD — coronary artery disease
depending on the distribution. The Kolmogorov-Smirn-
ov test was used to assess normality of distribution of 
the investigated parameters. Comparison between 
groups was performed by means of the Chi-square test 
for categorical variables, the unpaired Student’s t-test 
for normally distributed variables, and the Mann-Whit-
ney U-test for non-normally distributed variables. The 
association between variables was calculated with the 
Spearman and Kendall correlation coefficient where 
appropriate. P values lower than 0.05 were considered 
statistically significant.
Application of classification matrix, classification 
tree and patient dataset
A classification technique is a systematic approach 
to building classification models from an input data set. 
Each technique employs a learning algorithm to iden-
tify a model that best fits the relationship between the 
attribute set and class label of the input data. General 
approach for building a classification model is shown 
in Figure 1. The classification matrix gives estimates 
of the true classification and misclassification rules, 
and allows the evaluation of the performance of the 
designed model. Most classification algorithms seek 
models that attain the highest accuracy and, equiva-
lently, the lowest error rate (ER) when applied to the 
test dataset. 
Figure 1. General approach for building a classification model
16
folia Medica copernicana 2015, vol. 3, no. 1
www.fmc.viamedica.pl
Table 2. Classification matrix in the diagnostic test for the occurrence of ACS
Observed class
Classification matrix
Predicted class
ACS = 0
Predicted class
ACS = 1 Total in line
ACS = 0 36 6 42
% in the column 100.00 4.55
% in the line 85.71 14.29
% in total 21.43 3.57 25.00
ACS = 1 126 126
% in the column 0.00 95.45
% in the line 0.00 100.00
% in total 0.00 75.00 75.00
Total number 36 132 168
Total % 21.43 78.57
ACS — acute coronary syndrome
A tree-based classification and prediction model-
ing techniques use recursive partitioning to split the 
training records into segments with similar output 
variable values. The modeling starts by examining the 
input variables to find the best split, measured by the 
reduction on an impurity index that results from the 
split. The split defines two subgroups, each of which is 
subsequently split into two further subgroups, until the 
final criterion is met [5]. 
In our study, the initial patient dataset consisted of 
220 subjects, but the observations with incomplete or 
missing data of at least 1 variable were dropped from 
the dataset. Therefore, the final ready to use patient 
dataset for our classification matrix and diagnostic de-
cision tree consisted of 168 subjects. The model was 
optimized from a set of available clinical, laboratory 
and demographic variables, i.e. age, sex, body mass 
index (BMI), diabetes, hypertension, CRP, lipid profile 
and lipid ratios. Additionally, accuracy and ER for the 
model were calculated. 
Statistical analysis, classification and decision tree 
modeling were performed using SPSS 17.0 software 
package (SPSS, Chicago, IL, USA).
Results
Baseline characteristics of the study participants, 
including lipid parameters, CRP, apolipoproteins con-
centrations and calculated lipid ratios constituting major 
cardiovascular risk factors are shown in Table 1. Pa-
tients with ACS had higher concentrations of TC, LDL-C, 
non-HDL-C, and TG, but lower levels of HDL-C and 
apoA-I compared with controls. They also presented 
significantly higher values of atherogenic ratios such as 
TC:HDL-C, LDL-C:HDL-C, apoB:apoA-I, and TG:HDL-C. 
Both groups were characterized by the presence of 
dyslipidemia, hypertension, and smoking. A quarter 
of ACS patients were diagnosed with type 2 diabetes.
In ACS patients, the univariate analysis showed 
direct relationships of TG:HDL-C with the positive family 
history of CAD (Kendall’s tau = 0.13; p < 0.01) and age 
(R = –0.34; p < 0.0001). Among other variables, all the 
lipid parameters and ratios were significantly correlated 
with TG:HDL-C, except for LDL-C. There were no statis-
tically significant relationships between the TG: HDL-C 
ratio and sex, diabetes, hypertension, BMI and CRP.
Evaluation of the performance of classification 
model for the occurrence of ACS was depicted in 
Table 2. The diagnostic model correctly classified all 
subjects as having ACS, and incorrectly classified 
6 subjects. Therefore, we assumed that the diagnostic 
test based on the decision tree analysis correctly clas-
sified all ACS cases and allowed the identification of 
additional 6 subjects, who were incorrectly classified 
as non-ACS, as having ACS. 
Finally, we developed a decision tree constituting 
a diagnostic test for the occurrence of ACS. Among 
available patient data, the most important classifiers in 
the model included: TC:HDL-C ratio (the optimal cutoff 
3.27), age (the optimal cutoff 61.5 years), LDL:HDL-C 
ratio (the optimal cutoff 2.45), diabetes and, finally, 
TG:HDL-C ratio with the optimal cutoff 2.28 (Fig. 2). 
Performance metric calculated for this model included 
accuracy and the overall ER calculation, which were as 
follows: accuracy of 96.4% and ER of 0.03%.
Table 3 and Figure 3 summarize the importance 
of selected variables for the occurrence of ACS in 
the range of 1 to 0.05. The most important variables 
were: age, followed by TG:HDL-C, HDL-C and CRP. In 
contrast, the least important variables included family 
history of CAD, BMI and hypertension. 
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Figure 2. The diagnostic tree for evaluation of patients with ACS
ACS — acute coronary syndrome; LDL-C —  low-density lipoprotein cholesterol; HDL-C — high-density lipoprotein cholesterol; TC — total  
cholesterol; TG — triglycerides
Table 3. Ranking of predictors in the evaluation of ACS 
patients
Variable
Ranking of predictors of ACS
Rank Importance
Age 100 1.000
TG:HDL-C 83 0.831
HDL-C 72 0.717
CRP 57 0.569
Diabetes 56 0.559
TG 53 0.534
LDL:HDL-C 53 0.529
non-HDL-C 48 0.482
TC:HDL-C 47 0.473
ApoB:ApoAI 46 0.459
LDL-C 41 0.411
TC 38 0.377
ApoB 35 0.346
Sex 30 0.296
Smoking 29 0.292
ApoAI 24 0.244
Hypertension 18 0.184
BMI 12 0.117
Family history of 
premature CAD
5 0.052
ACS — acute coronary syndrome; TG — triglycerides;  HDL-C — high-
-density lipoprotein cholesterol; CRP — C-reactive protein; LDL-C — low- 
-density lipoprotein cholesterol; ApoAI — apolipoprotein A-I; ApoB — apoli-
poprotein B; BMI — body mass index; CAD — coronary artery disease
Discussion
We found the ratio of TG:HDL-C to be a powerful 
independent predictor and classifier of the occurrence 
of ACS. Moreover, the TG:HDL-C ratio was, after age, 
the second most important predictor of the occurrence 
of ACS, stronger than other traditional and lipid risk 
factors. Additionally, ACS patients showed almost twice 
as high median values of TG:HDL:C as controls. Im-
portantly, both median TG:HDL-C value of 2.77 and 
TG:HDL-C classifier value of 2.28 in ACS patients 
were below the cutoff that characterizes a high risk 
(TG:HDL-C ≥ 4.0), but above the value considered 
as optimal (TG:HDL-C < 2.00). The performance of 
TG:HDL-C in the diagnostic test presented by using 
decision tree analysis seems to be superior to other 
lipid parameters and ratios and enables the identifica-
tion of the additional 6 subjects with ACS. The principal 
advantage of decision trees analysis is the lack of any 
presuppositions concerning the distribution of data. 
They are particularly useful in situations with correlated 
data. This is very important in the analysis of lipid parame - 
ters which, because of the common metabolic link, are 
strongly correlated with each other. Traditional statistical 
approach, even with the use of logistic regression, in this 
case is imperfect and may lead to an underestimation of 
the effects of certain lipid variables. In addition, on the 
basis of the decision trees it is easy to develop a variety 
of diagnostic standards or therapeutic procedures.
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The TG:HDL-C ratio can easily be calculated from 
the lipid profile by dividing TG by HDL-C concentration. 
The TG:HDL-C ratio has been proposed by Gaziano et 
al., and recently has been proven to be a significant 
independent predictor of myocardial infarction, even 
stronger than other indices, including TC:HDL-C and 
LDL-C:HDL:C ratios. The initial data of Gaziano et al. 
suggest that TG:HDL-C ratio may be an important 
marker of abnormal TG metabolism, which may provide 
valuable additional information about the atherogenic 
potential of a lipid profile for the risk assessment [6]. 
These findings have recently been confirmed by oth-
ers. Basically, the atherogenicity of the TG:HDL-C ratio 
results from higher TG and lower HDL-C concentra-
tions. The state also known as residual risk is obviously 
shown by the presence of triglyceride-rich lipoproteins 
(TRL) found in fasting conditions in very low-density lipo-
proteins (VLDL) and in their remnants, and postprandial 
in chylomicrons and chylomicron remnants [7]. TRL 
particles are prone to undergo dynamic remodeling in 
the circulation which, in turn, results in the increased 
secretion of small, dense LDL during lipid exchange 
and lipolysis [7, 8]. Interestingly, it has been found that 
TG:HDL-C ratio can also predict the particle size of LDL 
and is associated with the presence of small dense LDL. 
Studies revealed that the elevated TG:HDL-C ratio (> 3.5) 
would suggest that the predominant LDL particle size 
is small in 80% of patients [9, 10]. 
In the Copenhagen General Population Study, 
lower concentrations of HDL-C were associated with 
higher concentrations of cholesterol and TRL rem-
nants. In this study, 45% of men and 30% of women 
had TG ≥ 150 mg/dL and/or HDL-C < 40 mg/dL [11]. 
The ACS patients in our study were also characterized 
by lower concentrations of HDL-C and higher TG 
concentrations than healthy subjects, but their values 
were still within recommended ranges. The fact that 
subjects with higher TG:HDL-C ratio have a tenden-
cy to have higher TG > 100 mg/dL concentrations 
is indeed commonly known. Large epidemiological 
studies have clearly shown that both elevated TG and 
reduced HDL-C concentrations are associated with 
the increased cardiovascular risk. Whereas HDL-C 
displays athero- and vasculo-protective activity and was 
associated with a 22% reduction (per 1 SD increase by 
0.38 mmol/L) in CAD risk, coronary risk increased by 
37% (95% CI, 31–42%) per 1 SD increase in log TG [12]. 
Moreover, early reports from the Copenhagen Male 
Study showed that atherogenic dyslipidemia with the 
presence of high TG and low HDL-C concentrations was 
at least as powerful predictor of CAD as isolated high 
LDL-C concentrations in insulin-resistant subjects [11]. 
Therefore, TG:HDL-C ratio is also considered an inde-
pendent marker of insulin resistance. 
Interestingly, genetic studies provide potential evi-
dence for cardiovascular risk associated with changes 
Figure 3. The importance of different classifiers in the evaluation of patients with acute coronary syndrome 
TG — triglycerides; HDL-C — high-density lipoprotein cholesterol; CRP — C-reactive protein; LDL-C — low-density lipoprotein cholesterol;  
ApoAI — apolipoprotein A-I; ApoB — apolipoprotein B; TC — total cholesterol; BMI — body mass index
19
Magdalena Krintus et al., The performance of triglyceride to high-density lipoprotein cholesterol ratio 
www.fmc.viamedica.pl
in TG rather than HDL-C concentrations, which is not 
necessarily unexpected taking into account the com-
plexity of metabolic pathways, especially for HDL-C [7]. 
We must acknowledge the important limitations of 
our study. We studied a selected, high-risk subset of 
patients who showed a higher prevalence of multiple 
risk factors than general population. Additionally, we did 
not include cardiac markers and electrocardiography, 
and did not take into account the use of statin therapy, 
which may weaken the inter-relationships between 
LDL-C and other lipid parameters.
In conclusion, our study indicates that the TG:HDL-C 
ratio is a useful risk marker of the ACS occurrence. 
Further prospective studies are needed to confirm our 
findings and clarify the interaction between TG and 
HDL-C concentrations in ACS patients.
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